Olive Oil's Attenuating Effects on Lipotoxicity
- PMID: 39287875
- DOI: 10.1007/978-3-031-63657-8_29
Olive Oil's Attenuating Effects on Lipotoxicity
Erratum in
-
Correction to: Olive Oil's Attenuating Effects on Lipotoxicity.Adv Exp Med Biol. 2024;1460:C1. doi: 10.1007/978-3-031-63657-8_32. Adv Exp Med Biol. 2024. PMID: 39592555 No abstract available.
Abstract
Dietary fatty acids play a role in the pathogenesis of obesity-associated nonalcoholic fatty liver disease. Lipotoxicity in obesity mediates insulin resistance, endothelial dysfunction, atherosclerosis, and gut microbiota dysbiosis. Cardiovascular complications are the main cause of morbidity and mortality in obese, insulin-resistant, and type 2 diabetes mellitus patients.Interventions targeting lipotoxicity are the main issue in preventing its multiple insults. Lifestyle modifications including healthy eating and regular exercise are the primary recommendations. Treatments also include drugs targeting energy intake, energy disposal, lipotoxic liver injury, and the resulting inflammation, fibrogenesis, and cirrhosis.Diet and nutrition have been linked to insulin resistance, an increased risk of developing type 2 diabetes, and impaired postprandial lipid metabolism. Low-fat diets are associated with higher survival. The Mediterranean diet includes an abundance of olive oil. Extra-virgin olive oil is the main source of monounsaturated fatty acids in Mediterranean diets. An olive oil-rich diet decreases triglyceride accumulation in the liver, improves postprandial triglyceride levels, improves glucose and insulin secretions, and upregulates GLUT-2 expression in the liver. The exact molecular mechanisms of olive oil's effects are unknown, but decreasing NF-kB activation, decreasing LDL oxidation, and improving insulin resistance by reducing the production of inflammatory cytokines (TNF-α and IL-6) and upregulating kinases and JNK-mediated phosphorylation of IRS-1 are possible principal mechanisms. Olive oil phenolic compounds also modulate gut microbiota diversity, which also affects lipotoxicity.In this review, we document lipotoxicity in obesity manifestations and the beneficial health effects of the Mediterranean diet derived from monounsaturated fatty acids, mainly from olive oil.
Keywords: Atherosclerosis; Dysbiosis; Endothelial dysfunction; Fatty liver; Gut microbiota; Inflammation; Insulin resistance; Lipotoxicity; Obesity; Olive oil; Steatohepatitis.
© 2024. The Author(s), under exclusive license to Springer Nature Switzerland AG.
Similar articles
-
Lipotoxicity in Obesity: Benefit of Olive Oil.Adv Exp Med Biol. 2017;960:607-617. doi: 10.1007/978-3-319-48382-5_26. Adv Exp Med Biol. 2017. PMID: 28585218 Review.
-
Extra virgin olive oil improved body weight and insulin sensitivity in high fat diet-induced obese LDLr-/-.Leiden mice without attenuation of steatohepatitis.Sci Rep. 2021 Apr 15;11(1):8250. doi: 10.1038/s41598-021-87761-3. Sci Rep. 2021. PMID: 33859314 Free PMC article.
-
Olive oil consumption and non-alcoholic fatty liver disease.World J Gastroenterol. 2009 Apr 21;15(15):1809-15. doi: 10.3748/wjg.15.1809. World J Gastroenterol. 2009. PMID: 19370776 Free PMC article. Review.
-
Polyphenol-rich virgin olive oil reduces insulin resistance and liver inflammation and improves mitochondrial dysfunction in high-fat diet fed rats.Mol Nutr Food Res. 2017 Mar;61(3). doi: 10.1002/mnfr.201600418. Epub 2016 Dec 20. Mol Nutr Food Res. 2017. PMID: 27794174
-
Impact of Olive Oil Components on the Expression of Genes Related to Type 2 Diabetes Mellitus.Nutrients. 2025 Feb 3;17(3):570. doi: 10.3390/nu17030570. Nutrients. 2025. PMID: 39940428 Free PMC article. Review.
References
-
- Adams JM, Pratipanawatr T, Berria R et al (2004) Ceramide content is increased in skeletal muscle from obese insulin resistant humans. Diabetes 53:25–31 - PubMed
-
- Andrade S, Borges N (2009) Effect of fermented milk containing Lactobacillus acidophilus and Bifidobacterium longum on plasma lipids of women with normal or moderately elevated cholesterol. J Dairy Res 76:469–474 - PubMed
-
- Anowski M, Blachnio-Zabielska A, Hirnle T et al (2010) Myocardium of type 2 diabetic and obese patients is characterized by alterations in sphingolipid metabolic enzymes but not by accumulation of ceramide. J Lipid Res 51:74–80
-
- Bajaj M, Suraamornkul S, Pratipanawatr T et al (2003) Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes mellitus. Diabetes 52:1364–1370 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials